You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 65 No. 1, January 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 •VIDEO SUPPLEMENT
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Genetic Disorders
 •Ataxia
 •Neurogenetics
 •Neuromuscular diseases
 •Tremor
 •Alert me on articles by topic

POLG1 Mutations Manifesting as Autosomal Recessive Axonal Charcot-Marie-Tooth Disease

Timothy Harrower, MRCP; Joanna D. Stewart, BSc; Gavin Hudson, PhD; Henry Houlden, MRCP(UK); Graham Warner, MRCP; Dominic G. O’Donovan, FRCPath; Leslie J. Findlay, FRCP; Robert W. Taylor, PhD; Rajith De Silva, FRCP; Patrick F. Chinnery, PhD, FRCP

Arch Neurol. 2008;65(1):133-136.

Background  Although a molecular diagnosis is possible in most patients having Charcot-Marie-Tooth disease (CMT), recessively inherited and axonal neuropathies still present a diagnostic challenge.

Objective  To determine the cause of axonal CMT type 2 in 3 siblings.

Design  Case report.

Setting  Academic research.

Participants  Three siblings who subsequently developed profound cerebellar ataxia.

Main Outcome Measures  Muscle biopsy specimen molecular genetic analysis of the POLG1 (polymerase {gamma}-1) gene, as well as screening of control subjects for POLG1 sequence variants.

Results  Cytochrome c oxidase deficient fibers and multiple deletions of mitochondrial DNA were detected in skeletal muscle. Three compound heterozygous substitutions were detected in POLG1.

Conclusion  Even in the absence of classic features of mitochondrial disease, POLG1 should be considered in patients having axonal CMT that may be associated with tremor or ataxia.


Author Affiliations: Departments of Neurology (Drs Harrower, O’Donovan, Findlay, and De Silva) and Neuropathology (Dr O’Donovan), Essex Centre for Neurological Sciences, Queen's Hospital, Romford; Mitochondrial Research Group, The Medical School (Drs Hudson, Taylor, and Chinnery and Ms Stewart), and Institute of Human Genetics (Drs Taylor and Chinnery), Newcastle University, Newcastle upon Tyne; Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London (Dr Houlden); and Department of Neurology, Royal Surrey County Hospital, Guildford (Dr Warner); England.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.